A

AstraZeneca

Global pharmaceutical company developing prescription medicines

Associate Principal Scientist - Vaccine Drug Product Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeGaithersburg, MD, USA

About the Job

Requirements

  • A BS, MS, or PhD in Biochemistry, Chemistry, Chemical or Biochemical Engineering, Immunology, Pharmaceutics, or a related field of study.
  • For candidates with a BS, at least 10 years of biopharmaceutical or vaccine development experience; with an MS, at least 7 years; or with a PhD, at least 5 years.
  • Hands-on experience with one or more of the following modalities: bioconjugates, virus-like particles, messenger RNA lipid nanoparticles, or recombinant protein vaccines.
  • Demonstrated expertise in vaccine adjuvant systems, including aluminum salts, lipid-based systems, or other novel adjuvants, and co-formulated multi-antigen/adjuvant products.
  • A proven track record in good manufacturing practice manufacturing, technology transfer to contract manufacturing organizations or contract development and manufacturing organizations, and clinical supply support.
  • Ability to independently design vaccine formulation studies and strategies addressing antigen–adjuvant interactions, adsorption, excipient selection, immunogenicity, and chemical, physical, and colloidal stability.
  • Ability to apply fit-for-purpose biophysical, biochemical, and compendial methods, including dynamic light scattering, chromatography, mass spectrometry, spectroscopy, binding assays, thermal analysis, particle characterization, adsorption profiling, residuals, osmolality, sterility/endotoxin, and appearance assessments.
  • Ability to develop and scale vaccine unit operations, including mixing, homogenization/emulsification, suspension handling, sterile filtration, fill-finish, and lyophilization, and support process robustness and technology transfer.
  • Ability to translate development processes into manufacturing-ready operations; review batch records; support GMP manufacturing, investigations, and clinical supply; and work with internal sites and external manufacturing partners.
  • Ability to author and review chemistry, manufacturing, and controls sections for investigational new drug applications, biologics license applications, and marketing authorization applications; contribute to responses to information requests; and support health authority queries with scientific rationales for formulation and process decisions.
  • Ability to design experiments with clear criteria, assess technical risks, and convert complex data into evidence-based recommendations for formulation, process, and CMC strategy.
  • Ability to communicate complex findings clearly, influence multidisciplinary stakeholders, and build partnerships across functions and external organizations.
  • Demonstrated technical impact through mentoring, capability building, conference presentations, publications, patents, or comparable scientific contributions.
  • Ability to anticipate risks and opportunities and drive timely, high-quality execution with minimal supervision.
  • Ability to build relationships across disciplines, communicate clearly, and foster transparency and shared accountability.
  • Commitment to translating technical work into better patient outcomes while prioritizing quality and safety.
  • Commitment to data integrity, methodical experimentation, clear documentation, and incorporating feedback to improve outcomes.

Responsibilities

  • Provide independent scientific and technical leadership for vaccine drug product programs from early formulation development through pivotal clinical development and manufacturing readiness.
  • Define development strategies; integrate formulation, process, analytical, regulatory, and manufacturing considerations; and translate complex data into clear program decisions.
  • Lead formulation development for multi-antigen/adjuvant products and other vaccine modalities; define studies, selection criteria, and control strategies addressing antigen–adjuvant interactions, compatibility, immunogenicity, and product stability across clinical phases.
  • Partner with Analytical Sciences to define fit-for-purpose methods and data expectations for vaccine and adjuvant characterization, ensuring analytical evidence supports formulation selection, process understanding, comparability, and control strategies.
  • Lead development, scale-up, characterization, and robustness studies for vaccine drug product processes; build process–product understanding, assess risks, and translate processes into reproducible, GMP-ready operations.
  • Lead technology transfer to internal sites and external manufacturing partners, review manufacturing documentation, and support engineering, clinical, and GMP batches; oversee execution and resolve technical issues, deviations, and process risks.
  • Serve as the Drug Product CMC representative, shaping program strategy, development plans, milestones, and risk management; align cross-functional teams and drive timely, evidence-based decisions.
  • Author and review technical documents and CMC content for regulatory submissions; develop scientific rationales, respond to information requests, and support health authority interactions.
  • Integrate experimental and manufacturing data into clear recommendations for formulation, process, clinical supply, and CMC decisions; build evidence packages for internal governance and regulatory review.
  • Direct external partners, align scope and timelines, and resolve scientific and operational issues.
  • Communicate findings, mentor scientists, and strengthen technical capabilities and project delivery.

About the Company

AstraZeneca

Global pharmaceutical company developing prescription medicines

AstraZeneca develops and markets prescription medicines and vaccines worldwide, with a focus on oncology, cardiovascular/metabolic, respiratory, and infectious diseases. Its products work by targeting specific biological pathways or cells, using small-molecule therapies, biologics, and vaccines to treat diseases or prevent infections. It differentiates itself through its dual heritage from Sweden and the UK, a broad pipeline, and strong R&D and collaborations that move from discovery to patient access. Its goal is to improve people’s health by discovering, developing, and delivering medicines and vaccines to patients worldwide.

Company size
10,001+
Company stage
IPO
Headquarters
Cambridge, United Kingdom
Founded
1913

Recently Posted Jobs

Explore more opportunities at AstraZeneca

See more jobs